跳至主要内容
临床试验/NCT06650085
NCT06650085招募中不适用

PROtective ileoStomy Versus ProtectivE Colostomy in Anterior Rectal resectIon - a Multicenter, Open-label, Randomized conTrolled studY (PROSPERITY)

Helsinki University Central Hospital6 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2025年10月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
350
试验地点
6
主要终点
Stoma-related adverse events

研究概览

简要总结

Loop ileostomy and loop colostomy are both used as protective stomas after anterior resection. There is a lack of evidence on the superiority of loop ileostomy versus loop colostomy. This is a multicenter, open-label, superiority, individually randomized controlled trial including patients undergoing anterior rectal resection with primary anastomosis and a protective stoma. Patients scheduled for anterior rectal resection are randomized 1:1 to loop ileostomy or loop colostomy intraoperatively. Primary outcome is cumulative stoma-related adverse events within 60 days post-primary surgery (scored using Comprehensive Complication Index (CCI)).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing anterior resection (resection of the rectum and colorectal or coloanal anastomosis) due to a rectal tumour and a protective stoma is planned.

排除标准

  • are: (1) patient already having a stoma (or another stoma made during surgery), (2) technical inability to create ileo- or colostomy (e.g. previous bowel resection, anatomical factors), (3) age <18 years, (4) inadequate ability to co-operate.

研究组 & 干预措施

Loop ileostomy

Experimental

干预措施: Loop ileostomy (Procedure)

Loop colostomy

Active Comparator

干预措施: Loop colostomy (Procedure)

结局指标

主要结局

Stoma-related adverse events

时间窗: Within 60 days from randomization

Stoma-related adverse events score by using Comprehensive Complication Index

次要结局

  • Postoperative complications(Within 30 days from randomization)
  • Postoperative complications after stoma closure(Within 30 days from stoma closure)
  • Hospital-free days(Within 30 days from randomization)
  • Quality of life(At 2 months from randomization)
  • Kidney function change(Within 1 year from randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ville Sallinen

Adj. Professor

Helsinki University Central Hospital

研究点 (6)

Loading locations...

相似试验